Ac. Trillat et al., EFFECTS OF WAY-100635 AND (-)-5-ME-8-OH-DPAT, A NOVEL 5-HT1A RECEPTORANTAGONIST, ON 8-OH-DPAT RESPONSES, European journal of pharmacology, 347(1), 1998, pp. 41-49
The neurochemical profile at both post and presynaptic 5-MT1A receptor
s of a novel 8-hydroxp-2-(di-n-propylamino)tetralin (8-OH-DPAT) analog
, 5-methyl-8-hydroxy-2-(di-n-propylamino)tetralin ((+/-)-5-Me-8-OH-DPA
T) and its stereoisomers was determined and compared to that of the hi
ghly selective 5-MT1A receptor antagonist, 4-(2-methoxyphenyl)-1-piper
azinyl]-N-(2-pyridinyl) cyclo-hexanecarboxamide (WAY 100635). We evalu
ated their effects on 8-OH-DPAT-induced decrease in cAMP production, o
n 8-OH-DPAT-induced decrease in rat ventral hippocampal extracellular
5-hydroxytryptamine (5-MText) levels and in body temperature in mice.
Both (+/-)- and (-)-5-Me-8-OH-DPAT blocked the 8-OH-DPAT-induced inhib
ition of forskolin-stimulated cAMP production. Moreover, while having
no significant effect when injected alone, (+/-)-, (-)-5-Me-8-OH-DPAT
and WAY 100635 antagonized the 8-OH-DPAT-induced decrease in 5-MText i
n rats and hypothermia in mice. By contrast, the (+) isomer inhibited
the cAMP synthesis and did not modify the 8-OH-DPAT response on 5-MTex
t in ventral hippocampus. These data suggest that (+/-)-5-Me-8-OH-DPAT
acts selectively, its activity residing in the(-) enantiomer, this la
tter compound acting similarly to WAY 100635 as a full, selective and
silent 5-MT1A antagonist. (C) 1998 Elsevier Science B.V.